Investigative Sites

Strategies to successfully manage the business of clinical trials in today's environment.

Detailed instructions for creating strong SOPs that can serve as the backbone of studies and sites.

Proposed "lottery" or deferred payment model aims to resolve undue inducement.

European community weighs in on challenges to pediatric research in this survey from EUCROF.

Advancing medicine and the clinical research process with the help of patient organizations

Overcoming hurdles in subject enrollment by managing potential risks in six critical key areas.

A look into the evolving relationship and what motivates the two to work together.

Concerns are being put into action with the trend toward better investigator training.

Ways to ensure the transition between vendors is as smooth as possible for everyone involved.

A look into how flow cytometrycan benefit global clinical trials and what an IT savvy central lab can contribute.

Mobile phones enable innovative tele-, home-, and health-monitoring solutions for clinical trial subjects.

How this electronic data capture technology enhanced clinical trial design for two allergy studies.

Integrating a study's eClinical systems enables more effective management and eliminates pesky redundancies.

The potential for transformation within the clinical research process is here and now. Are you ready?

The use of computer simulation models to improve both site selection and subject recruitment.

Real-time financial performance indicator for clinical research sites that answers the question, how are we doing?

The impact of proactive subject recruitment planning.

How one research project in South Africa developed its own benchmark assessment tool to gauge performance and compliance across sites.

Today's problem-plagued feasibility assessment process is in need of repair.

Just like pharma, biotech companies need clinical research organizations too, but are their needs different?

Why this age-old industry staple is missing the mark for many and what can be done to remedy the situation.

A call to sponsors to rethink the role of ECGs in drug development and the use of central core labs.

Pilot test to rebrand clinical research shows promise as a way to build public trust and promote interest.